Related references
Note: Only part of the references are listed.Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study
Helen A. Kelly et al.
PLOS MEDICINE (2021)
Estimates of the global burden of cervical cancer associated with HIV
Dominik Stelzle et al.
LANCET GLOBAL HEALTH (2021)
Cervical cancer risk in women living with HIV across four continents: A multicohort study
Eliane Rohner et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
An on-going study of three different cervical cancer screening strategies based on primary healthcare facilities in Beijing China
Lili Han et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2020)
Risk of CIN2 or more severe lesions after negative HPV-mRNA E6/E7 overexpression assay and after negative HPV-DNA test: Concurrent cohorts with a 5-year follow-up
Manuel Zorzi et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Primary HPV testing with cytology versus cytology alone in cervical screening-A prospective randomized controlled trial with two rounds of screening in a Chinese population
Karen K. L. Chan et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
Marc Arbyn et al.
LANCET GLOBAL HEALTH (2020)
Psycho-social impact of positive human papillomavirus testing in Jujuy, Argentina results from the Psycho-Estampa study
Silvina Arrossi et al.
PREVENTIVE MEDICINE REPORTS (2020)
HPV-mRNA and HPV-DNA detection in samples taken up to seven years before severe dysplasia of cervix uteri
Ola Forslund et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Effectiveness of cervical cancer screening at age 65-A register-based cohort study
Maiju Pankakoski et al.
PLOS ONE (2019)
Cross-sectional study of HPV testing in self-sampled urine and comparison with matched vaginal and cervical samples in women attending colposcopy for the management of abnormal cervical screening
Alex Sargent et al.
BMJ OPEN (2019)
Programmatic human papillomavirus testing in cervical cancer prevention in the Jujuy Demonstration Project in Argentina: a population-based, before-and-after retrospective cohort study
Silvina Arrossi et al.
LANCET GLOBAL HEALTH (2019)
Performance of Two-Stage Cervical Cancer Screening With Primary High-Risk Human Papillomavirus Testing in Women Living With Human Immunodeficiency Virus
Rebecca Luckett et al.
OBSTETRICS AND GYNECOLOGY (2019)
Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany
Thomas Iftner et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2019)
Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial
Nicole J. Polman et al.
LANCET ONCOLOGY (2019)
Relative Performance of HPV and Cytology Components of Cotessting in Cervical Screening
Mark Schiffman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Relative Performance of HPV and Cytology Components of Cotessting in Cervical Screening
Mark Schiffman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study
Mariam El-Zein et al.
GYNECOLOGIC ONCOLOGY (2018)
Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL randomized clinical trial (vol 320, pg 43, 2018)
G. S. Ogilvie et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis
Helen Kelly et al.
LANCET HIV (2018)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2018)
Durability of clinical performance afforded by self-collected HPV testing: A 15-year cohort study in China
Li Zhang et al.
GYNECOLOGIC ONCOLOGY (2018)
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses
Marc Arbyn et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis
Erik J. Nelson et al.
SEXUALLY TRANSMITTED INFECTIONS (2017)
Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial
Karen Canfell et al.
PLOS MEDICINE (2017)
Triage of HPV positive women in cervical cancer screening
Nicolas Wentzensen et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands
Maaike G. Dijkstra et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands
Maaike G. Dijkstra et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Carcinogenic human papillomavirus infection
Mark Schiffman et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Adjunct screening of cervical or vaginal samples using careHPV testing with Pap and aided visual inspection for detecting high-grade cervical intraepithelial neoplasia
Smita Asthana et al.
CANCER EPIDEMIOLOGY (2015)
Diagnostic accuracy of VIA and HPV detection as primary and sequential screening tests in a cervical cancer screening demonstration project in India
Partha Basu et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial
Silvina Arrossi et al.
LANCET GLOBAL HEALTH (2015)
Effect of VIA Screening by Primary Health Workers: Randomized Controlled Study in Mumbai, India
Surendra S. Shastri et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Reassurance Against Future Risk of Precancer and Cancer Conferred by a Negative Human Papillomavirus Test
Julia C. Gage et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Guglielmo Ronco et al.
LANCET (2014)
Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial
K. Miriam Elfstrom et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
A randomized trial comparing conventional cytology to liquid-based cytology and computer assistance
Stefanie J. Klug et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Validation of Cervical Cancer Screening Methods in HIV Positive Women from Johannesburg South Africa
Cynthia Firnhaber et al.
PLOS ONE (2013)
Screening for cervical cancer: a systematic review and meta-analysis
Leslea Peirson et al.
SYSTEMATIC REVIEWS (2013)
Having a Pap smear, quality of life before and after cervical screening: a questionnaire study
I. J. Korfage et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2012)
Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial
Dorien C. Rijkaart et al.
LANCET ONCOLOGY (2012)
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Marc Arbyn et al.
VACCINE (2012)
Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland
Maarit K. Leinonen et al.
BRITISH MEDICAL JOURNAL (2012)
Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975
C. La Vecchia et al.
ANNALS OF ONCOLOGY (2010)
Optional screening strategies for cervical cancer using standalone tests and their combinations among low- and medium-income populations in Latin America and Eastern Europe
Luis Otavio Sarian et al.
JOURNAL OF MEDICAL SCREENING (2010)
Human Papillomavirus-Based Cervical Cancer Prevention: Long-term Results of a Randomized Screening Trial
Lynette Denny et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
Guglielmo Ronco et al.
LANCET ONCOLOGY (2010)
ARTISTIC: a randomised trial of-human-papillomavirus (HPV) testing in primary cervical screening
H. C. Kitchener et al.
HEALTH TECHNOLOGY ASSESSMENT (2009)
Evaluation of cervical screening in rural North India
Neerja Bhatla et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2009)
Comparison of Liquid-Based Cytology With Conventional Cytology for Detection of Cervical Cancer Precursors A Randomized Controlled Trial
Albertus G. Siebers et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
HPV Screening for Cervical Cancer in Rural India
Rengaswamy Sankaranarayanan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Comparison of the conventional cervical smear and liquid-based cytology - Results of a controlled, prospective study in the Abruzzo Region of Italy
Vincenzo Maccallini et al.
ACTA CYTOLOGICA (2008)
A randomised comparison of SurePath liquid-based cytology and conventional smear cytology in a colposcopy clinic setting
P. H. Sykes et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2008)
Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test
Guglielmo Ronco et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Coverage of cervical cancer screening in 57 countries: Low average levels and large inequalities
Emmanuela Gakidou et al.
PLOS MEDICINE (2008)
Liquid-based cytology versus conventional papanicolaou smear in an organized screening program -: A prospective Randomized study
Bjoern Strander et al.
CANCER CYTOPATHOLOGY (2007)
Human papillomavirus and papanicolaou tests to screen for cervical cancer
Pontus Naucler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial
Rengaswamy Sankaranarayanan et al.
LANCET (2007)
Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial
Guglielmo Ronco et al.
BRITISH MEDICAL JOURNAL (2007)
Human papillomavirus testing and liquid-based cytology: Results at recruitment from the new technologies for cervical cancer randomized controlled trial
Guglielmo Ronco et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Direct comparison of liquid-based and conventional cytology in a South African screening trial
S Taylor et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Screen-and-treat approaches for cervical cancer prevention in low-resource settings - A randomized controlled trial
L Denny et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India
R Sankaranarayanan et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Does liquid-based technology really improve detection of cervical neoplasia? A prospective, randomized trial comparing the ThinPrep Pap Test with the conventional Pap Test, including follow-up of HSIL cases
JH Obwegeser et al.
ACTA CYTOLOGICA (2001)
Share Paper
